Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Rhino Health

Explore full profile

Federated computing platform for privacy-preserving healthcare AI

Boston, United StatesFounded 2020Health Tech & Medtech
Valuation $0–100M Latest valuation · 2025
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Rhino Health and the history behind them.

About Rhino Health

Rhino Health provides a federated computing platform that enables secure data collaboration for AI development in healthcare and life sciences without moving data from its source. The company was co-founded by CEO Dr. Ittai Dayan and CTO Yuval Baror. Dr. Dayan's background combines clinical medicine, management consulting at Boston Consulting Group, and leading the Center for Clinical Data Science at Mass General Brigham. This experience, particularly leading a global federated learning project to predict COVID-19 progression, revealed the need for a platform that could overcome the challenges of centralizing sensitive patient data.

Read full description

The Rhino Federated Computing Platform (FCP) is built on federated learning and edge computing principles, which 'bring the code to the data'. This allows multiple institutions, such as hospitals, biopharma companies, and research organizations, to collaborate on training AI models using their distributed datasets while ensuring patient privacy, data security, and compliance with regulations like HIPAA and GDPR. The platform provides an end-to-end solution for the entire AI lifecycle, including federated data discovery, harmonization, model training, validation, and monitoring, which can be managed via a web interface or an SDK. A key feature is the 'Harmonization Copilot', which uses generative AI to automate the mapping of diverse data into a standard model.

The company's business model centers on providing this platform to a network of clients, including over 50 medical centers, life sciences companies, and public sector organizations. This approach accelerates the development of more accurate and equitable AI solutions for applications like drug discovery, disease prediction, and diagnostics in fields such as oncology and radiology, by leveraging larger, more diverse real-world data. Headquartered in Boston, MA, with an R&D center in Tel Aviv, Israel, Rhino Health has raised a total of $11.7M as of October 2022 and has established partnerships with Google Cloud and Nvidia.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
Boston, United States
Employees
31
Open positions
None listed
Dealroom signal
66.0/100
Industry
Health
Sub-industry
Medical Devices, Health Platform
Sector
Health Tech & Medtech, Privacy Protection, Core AI, Medical Data, Novel AI, Privacy-Enhancing Technologies, AI Applications, Health It
Technology
Artificial Intelligence, Deep Tech
Business model
SaaS
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Rhino Health.

See all news

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing May 2025 $15M $60M LionBird · Arkin Capital · Gaingels · Fusion Fund
EARLY VCOther financing Oct 2024 $0 TELUS Global Ventures
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Rhino Health website traffic

Latest recorded traffic for Rhino Health is 16K monthly website visits, up 290.2% over the last three months. Rhino Health's team declined 43.6% over the past year.

Latest monthly visits16K 3-month web change+290.2% 1-year team growth-43.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

Series A6 investors entered at this stage

  • TELUS Global Ventures
  • AlleyCorp
  • Gaingels
  • Qiming Venture Partners USA
  • Wilson’s Bird Capital
  • Frank Sica
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Rhino Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Rhino Health’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.